Inventor · disambiguated record
Marcelle Paulette Van Mechelen
Also filed as: VAN MECHELEN MARCELLE · VAN MECHELEN MARCELLE P · VAN MECHELEN MARCELLE PAULETTE
8 granted patents·15 pending applications·119 citations·filing 1998–2022
88Inventor score
Files withGLAXOSMITHKLINE BIOLOG SA5GLAXOSMITHKLINE BIOLOGICALS SA5SMITHKLINE BEECHAM BIOLOG5BIEMANS RALPH LEON4IMCYSE SA2
Top patents by PatentIndex Score
23 records- 0195US9884113B2Pneumoccal polysacchride conjugate vaccineGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2015·Granted Feb 6, 2018·13 cites·13 claims
- 0292US9107872B2Pneumococcal polysaccharide conjugate vaccineBIEMANS RALPH LEON·Filed 2009·Granted Aug 18, 2015·14 cites·10 claims
- 0391US10646564B2VaccineGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2019·Granted May 12, 2020·2 cites·9 claims
- 0490US10279033B2Vaccine comprising Streptococcus pneumoniae capsular polysaccharide conjugatesGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2016·Granted May 7, 2019·5 cites·1 claims
- 0588US9610339B2Vaccine comprising Streptococcus pneumoniae capsular polysaccharide conjugatesBIEMANS RALPH LEON·Filed 2008·Granted Apr 4, 2017·10 cites·16 claims
- 0688US9610340B2Vaccine comprising Streptococcus pneumoniae capsular polysaccharide conjugatesBIEMANS RALPH LEON·Filed 2008·Granted Apr 4, 2017·11 cites·16 claims
- 0785US6500432B1Method to enhance an immune response of nucleic acid vaccinationSMITHKLINE BEECHAM BIOLOG·Filed 1998·Granted Dec 31, 2002·64 cites·2 claims
- 0883US2022354941A1Pneumococcal capsular saccharide conjugate vaccineGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2022·Application pending·0 cites
- 0969US11400147B2Pneumococcal capsular saccharide conjugate vaccineGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2018·Granted Aug 2, 2022·0 cites·12 claims
- 1067US2015190521A1Pneumococcal capsular saccharide conjugate vaccineGLAXOSMITHKLINE BIOLOG SA·Filed 2014·Application pending·0 cites
- 1164US2009017072A1VaccineGLAXOSMITHKLINE BIOLOG SA·Filed 2006·Application pending·0 cites
- 1264US2009017059A1Vaccine Comprising Streptococcus Pneumoniae Capsular Polysaccharide ConjugatesGLAXOSMITHKLINE BIOLOG SA·Filed 2006·Application pending·0 cites
- 1363US2009010959A1Pneumococcal Polysaccharide Conjugate VaccineBIEMANS RALPH LEON·Filed 2006·Application pending·0 cites
- 1459US2005152892A1Epitopes or mimotopes derived from the C-epsilon-3 or C-epsilon-4 domains of IgE, antagonists thereof, and their therapeutics usesSMITHKLINE BEECHAM BIOLOG·Filed 2004·Application pending·0 cites
- 1553US2023340061A1Peptides and methods for the treatment of multiple sclerosisIMCYSE SA·Filed 2021·Application pending·0 cites
- 1653US2003147906A1Epitopes or mimotopes derived from the C-epsilon-3 or C-epsilon-4 domains of lgE, antagonists thereof, and their therapeutic usesSMITHKLINE BEECHAM BIOLOG·Filed 2002·Application pending·0 cites
- 1750US2023172894A1Combination treatment for fumarate-related diseasesIMCYSE SA·Filed 2021·Application pending·0 cites
- 1847US2003170229A1VaccineSMITHKLINE BEECHAM BIOLOG·Filed 2002·Application pending·0 cites
- 1944US2008069832A1VaccinesCHOMEZ PATRICK·Filed 2005·Application pending·0 cites
- 2043US2005214285A1Epitopes or mimotopes derived from the C-epsilon-3 or C-epsilon-4 domains of IgE, antagonists thereof, and their therapeutic usesSMITHKLINE BEECHAM BIOLOG·Filed 2004·Application pending·0 cites
- 2139US2014322272A1VaccineGLAXOSMITHKLINE BIOLOG SA·Filed 2012·Application pending·0 cites
- 2239US2014322271A1Vaccine comprising a tlr-5 agonist as adjuvant for use in cutaneous immunisationGLAXOSMITHKLINE BIOLOG SA·Filed 2012·Application pending·0 cites
- 2333US2003165503A1Vaccine for the treatment of atherosclerosisFiled 2001·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →